Are optimal doses of benazepril and losartan to reduce proteinuria more nephroprotective than conventional doses in non-diabetic proteinuric nephropathies? G. Fernández Juárez, V. Barrio

Dapagliflozin-induced hypercalcemia María Marques Vidas, Beatriz Dura Gurpide, Esther Rubio, Ana Huerta, José Portolés Pérez

Effect of early treatment with dapagliflozin on the natural history of chronic kidney disease Álvaro Marchán-López